Dual-functioning antimalarials that inhibit the chloroquine-resistance transporter

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Malaria remains a significant global health burden, necessitating novel therapeutic strategies.
• Emerging resistance to current antimalarial drugs, including artemisinin, highlights the urgent need for new treatments.
• Dual-function compounds represent a promising approach to combat drug resistance.

Purpose of the Study:

• To review the discovery and proposed mechanisms of novel dual-function antimalarials.
• To explore compounds targeting both hemozoin formation and the chloroquine resistance transporter (PfCRT).
• To discuss these agents in the context of 4-aminoquinoline action and resistance reversal.

Main Methods:

• Literature review of recent research on dual-function antimalarials.
• Analysis of proposed mechanisms of action targeting hemozoin formation.
• Examination of strategies to overcome chloroquine resistance via PfCRT modulation.

Main Results:

• Identification of dual-function compounds combining chloroquine-like antimalarial activity with chemosensitizing properties.
• Evidence suggests these compounds target both parasite heme detoxification and the PfCRT efflux pump.
• These novel agents show potential for overcoming established chloroquine resistance.

Conclusions:

• Dual-function antimalarials are a promising strategy to address drug resistance in malaria.
• Targeting both hemozoin formation and PfCRT offers a multi-pronged approach to malaria treatment.
• Further research into these compounds may lead to effective new therapies against resistant malaria strains.